In Ontario, the task of deciding which treatments to use for COVID-19 patients falls to two committees that weigh the evidence and choose which drugs to use, and how to manage critical illness.
Articles on COVID-19 treatment
Displaying 21 - 24 of 24 articles
Drug repurposing represents our only hope for the treatment of COVID-19 in the short term. But quick and rigorous trials need to be run to provide evidence these drugs work.
Coronavirus drug trials are underway – a virologist explains what the treatment options may be.
COVID-19 is creating overwhelming needs for intensive care and testing facilities. An Australian team is developing purpose-built units that can be shipped and erected quickly, easily and cheaply.
Top contributors
-
Head of School and Dean of Pharmacy, University of Sydney
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Professor, Head of School, School of Architecture, University of Technology Sydney
-
Associate Professor and Research Leader in Virology and Infectious Disease, Griffith University
-
Clinical Educator, Faculty of Pharmacy, University of Sydney
-
Director, Australian Living Evidence Collaboration; Professor (Research), School of Population Health and Preventive Medicine, Monash University
-
Pharmacist and PhD Candidate, University of Sydney
-
Emergency Physician and Clinician Scientist, University of Toronto
-
Professor of Medicine, University of Virginia
-
Research Assistant in the Department of Global Health, Boston University
-
Director, Intensive Care Unit, Alfred Health; Professor, Epidemiology and Preventative Medicine, Monash University
-
Professor of Medicine and Director, Center for Antibody Therapeutics, University of Pittsburgh
-
Professional Research Fellow, Victoria University
-
Associate professor, University of Sydney
-
Postdoctoral fellow, McGill University